Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-24T00:28:07.207Z Has data issue: false hasContentIssue false
  • English
  • Français

Prevalence and predictors of psychotropic medication use: results from the Northern Ireland Study of Health and Stress

Published online by Cambridge University Press:  15 September 2014

T. Benson ,
S. O'Neill ,
S. Murphy ,
F. Ferry  and
B. Bunting
T. Benson*
Affiliation:
School of Psychology, University of Ulster, Magee Campus, Northland Road, Londonderry, Northern Ireland BT48 7JL, UK
S. O'Neill
Affiliation:
School of Psychology, University of Ulster, Magee Campus, Northland Road, Londonderry, Northern Ireland BT48 7JL, UK
S. Murphy
Affiliation:
School of Psychology, University of Ulster, Magee Campus, Northland Road, Londonderry, Northern Ireland BT48 7JL, UK
F. Ferry
Affiliation:
School of Psychology, University of Ulster, Magee Campus, Northland Road, Londonderry, Northern Ireland BT48 7JL, UK
B. Bunting
Affiliation:
School of Psychology, University of Ulster, Magee Campus, Northland Road, Londonderry, Northern Ireland BT48 7JL, UK
*
*Address for correspondence: Mr T. Benson, School of Psychology, University of Ulster, Magee Campus, Northland Road, Room MB205, Londonderry, Northern Ireland BT48 7JL, UK. (Email: [email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Background.

To identify the predictors of psychotropic medication use and to determine rates and patterns of use in Northern Ireland (NI) among the general population and various subgroups.

Method.

Analysis of data from the NI Study of Health and Stress, a representative household survey undertaken between 2004 and 2008 with 4340 individuals. Respondents were asked about prescribed psychotropic medication use in the previous 12 months along with a series of demographic questions and items regarding experience of traumatic life events. Mental health disorders were assessed using the World Health Organization's Composite International Diagnostic Interview.

Results.

Females, individuals aged 50–64 years old, those who were previously married, and those who had experienced a traumatic lifetime event were more likely to have taken any psychotropic medication. Use of any psychotropic medication in the population in the previous 12 months was 14.9%. Use among individuals who met the criteria for a 12-month mental health disorder was 38.5%. Almost one in ten individuals (9.4%) had taken an antidepressant.

Conclusions.

Compared with other countries, NI has high proportions of individuals using psychotropic medication in both the general population and those who met the criteria for a 12-month mental disorder. However, these results still suggest possible under treatment of mental disorders in the country. In addition, rates of use in those with no disorder are relatively high. The predictors of medication use are similar to findings in other countries. Possible research and policy implications are discussed.

Keywords

Drug utilisationNorthern Irelandpsychopharmacologypsychotropic drugs
Type
Original Articles
Information
Epidemiology and Psychiatric Sciences , Volume 24 , Issue 6 , December 2015 , pp. 542 - 552
Copyright
Copyright © Cambridge University Press 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alonso, J, Angermeyer, MC, Bernert, S, Bruffaerts, R, Brugha, TS, Bryson, H, de Girolamo, G, Graaf, R, Demyttenaere, K, Gasquet, I, Haro, JM, Katz, SJ, Kessler, RC, Kovess, V, Lépine, JP, Ormel, J, Polidori, G, Russo, LJ, Vilagut, G, Almansa, J, Arbabzadeh-Bouchez, S, Autonell, J, Bernal, M, Buist-Bouwman, MA, Codony, M, Domingo-Salvany, A, Ferrer, M, Joo, SS, Martínez-Alonso, M, Matschinger, H, Mazzi, F, Morgan, Z, Morosini, P, Palacín, C, Romera, B, Taub, N, Vollebergh, WA (2004). Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatrica Scandinavica 420, 55–64.Google Scholar
American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. APA: Washington, DC.Google Scholar
Baldwin, DS, Kosky, N (2007). Off-label prescribing in psychiatric practice. Advances in Psychiatric Treatment 13, 414–422.Google Scholar
Beck, CA, Williams, JV, Wang, JL, Kassam, A, El-Guebaly, N, Currie, SR, Maxwell, CJ, Patten, SB (2005). Psychotropic medication use in Canada. Canadian Journal of Psychiatry 50, 605–613.Google Scholar
Bunting, BP, Murphy, S, O'Neill, S, Ferry, F (2013 a). Prevalence and treatment of 12-month DSM-IV disorders in the Northern Ireland study of health and stress. Social Psychiatry and Psychiatric Epidemiology 48, 81–93.Google Scholar
Bunting, BP, Ferry, F, Murphy, S, O'Neill, S, Bolton, D (2013 b). Trauma associated with civil conflict and posttraumatic stress disorder: evidence from the Northern Ireland study of health and stress. Journal of Traumatic Stress 26, 134–141.Google Scholar
Chien, IC, Bih, SH, Lin, CH, Chou, YJ, Lee, WG, Lee, CH, Chou, P (2011). Correlates and psychiatric disorders associated with psychotropic drug use in Taiwan. Social Psychiatry and Psychiatric Epidemiology 46, 77–84.Google Scholar
Cooperstock, R (1976). Psychotropic drug use among women. Canadian Medical Association Journal 115, 760–763.Google Scholar
Cooperstock, R, Parnell, P (1982). Research on psychotropic drug use: a review of findings and methods. Social Science & Medicine 16, 1179–1196.Google Scholar
Elger, BS, Geohring, C, Revaz, SA, Morabia, A (2002). Prescription of hypnotics and tranquilisers at the Geneva prison's outpatient service in comparison to an urban outpatient medical service. Sozial-und Präventivmedizin 47, 39–43.Google Scholar
Ferry, F, Bolton, D, Bunting, BP, Devine, B, McCann, S, Murphy, S (2008). Trauma, Health and Conflict in Northern Ireland. Northern Ireland Centre for Trauma and Transformation: Omagh. Retrieved 8 February 2013 from http://icrt.org.uk/wp-content/uploads/2012/11/08-May-Trauma-Health-Conflict-Report-first-reprint.pdf.Google Scholar
Gasquet, I, Medioni, J, Lellouch, J, Guelfi, JD (2002). Psychotropic prescription in non-psychiatric hospital settings. European Psychiatry 17, 414–418.Google Scholar
Gibson, T, Ozminkowski, R, Goetzel, R (2005). The effects of prescription drug cost sharing: a review of the evidence. American Journal of Managed Care 11, 730–740.Google Scholar
Goldney, R, Bain, M (2006). Prevalence of psychotropic use in a South Australian population. Australasian Psychiatry 14, 379–383.Google Scholar
Grandfils, N, Sermet, C (2009). Evolution 1998–2002 of the Antidepressant Consumption in France, Germany and the United Kingdom. Institut de recherche et documentation en économie de la santé: Paris. Retrieved 20 March 2013 from http://EconPapers.repec.org/RePEc:irh:wpaper:dt21.Google Scholar
Grinshpoon, A, Marom, E, Weizman, A, Ponizovsky, A (2007). Psychotropic drug use in Israel: results from the national health survey. Primary Care Companion to the Journal of Clinical Psychiatry 9, 356–363.Google Scholar
Health and Social Care Business Services Organisation (2011). Prescription Cost Analysis [data file]. Health and Social Care Business Services Organisation: Northern Ireland. Retrieved 10 March 2013 from http://www.hscbusiness.hscni.net/services/2266.htm.Google Scholar
Hosmer, DW, Lemeshow, S (1989). Applied Logistic Regression. John Wiley & Sons: New York.Google Scholar
Ingram Fogel, C, Fugate Woods, N (2008). Women's Health Care in Advanced Practice Nursing. Springer Publishing Company: New York.Google Scholar
Kessler, RC, Üstün, TB (2008). The World Health Organization composite international diagnostic interview. In The WHO World Mental Health Surveys: Global Perspectives on The Epidemiology of Mental Disorders (ed. Kessler, RC and Üstün, TB), pp. 58–90. Cambridge University Press: New York.Google Scholar
Lindström, M, Rosvall, M (2012). Marital status, social capital, economic stress, and mental health: a population-based study. Social Science Journal 49, 339–342.Google Scholar
Maguire, A, Hughes, C, Cardwell, C, O'Reilly, D (2013). Psychotropic medications and the transition into care: a national data linkage study. Journal of the American Geriatrics Society 61, 215–221.Google Scholar
McManus, P, Mant, A, Mitchell, PB, Montgomery, WS, Marley, J, Auland, ME (2000). Recent trends in the use of antidepressant drugs in Australia, 1990–1998. Medical Journal of Australia 173, 458–461.Google Scholar
National Advisory Committee on Drugs (2012). Bulletin 2: Drug use in Ireland and Northern Ireland. National Advisory Committee on Drugs: Ireland. Retrieved 2 March 2013 from http://www.drugs.ie/resourcesfiles/research/2012/drug_use_ireland2012.pdf.Google Scholar
Northern Ireland Statistics and Research Agency (2008). GP Data Mood and Anxiety Disorders [data file]. Northern Ireland Statistics and Research Agency: Northern Ireland. Retrieved 5 August 2013 from http://www.ninis2.nisra.gov.uk/public/Theme.aspx?themeNumber=134&themeName=Health+and+Social+Care.Google Scholar
Ohayon, MM, Lader, MH (2002). Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. Journal of Clinical Psychiatry 63, 817–825.Google Scholar
Olfson, M, Marcus, SC, Druss, B, Elinson, L, Tanielian, T, Pincus, HA (2002). National trends in the outpatient treatment of depression. Journal of the American Medical Association 287, 203–209.Google Scholar
O'Reilly, D (2011). Give my head peace: psychotropic drug uptake around the ‘peace-lines’ in Northern Ireland [abstract]. Journal of Epidemiology & Community Health 65, A14–A15.Google Scholar
Paulose-Ram, R, Jonas, BS, Orwig, D, Safran, MA (2004). Prescription psychotropic medication use among the U.S. adult population: results from the third National Health and Nutrition Examination Survey, 1988–1994. Journal of Clinical Epidemiology 57, 309–317.Google Scholar
Paulose-Ram, R, Safran, MA, Jonas, BS, Gu, Q, Orwig, D (2007). Trends in psychotropic medication use among U.S. adults. Pharmacoepidemiology & Drug Safety 16, 560–570.Google Scholar
Pennell, BE, Mneimneh, ZN, Bowers, A, Chardoul, S, Wells, JE, Viana, MC, Dinkelmann, K, Gebler, N, Florescu, S, He, Y, Huang, Y, Tomov, T, Saiz, GV (2008). Implementation of the World Mental Health Surveys. In The WHO World Mental Health Surveys: Global Perspectives on the Epidemiology of Mental Disorders (ed. Kessler, RC and Üstün, TB), pp. 33–57. Cambridge University Press: New York.Google Scholar
Pratt, LA, Brody, DJ, Gu, Q (2011). Antidepressant Use in Persons Aged 12 and Over: United States, 2005–2008. NCHS data brief, no 76. National Center for Health Statistics: Hyattsville, MD.Google Scholar
Rodrigues, MA, Facchini, LA, Lima, MS (2006). Modifications in psychotropic drug use patterns in a Southern Brazilian city. Revista de Saúde Pública 40, 107–114.Google Scholar
StataCorp (2011). Stata Statistical Software: Release 12. StataCorp LP: College Station, TX.Google Scholar
Stephenson, CP, Karanges, E, McGregor, IS (2013). Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011. Australian & New Zealand Journal of Psychiatry 47, 74–87.Google Scholar
Strom, BL (2006). Pharmacoepidemiology, 4th edn . Wiley: Chichester, UK.Google Scholar
Tedstone Doherty, D, Kartalova-O'Doherty, Y (2010). Gender and self-reported mental health problems: predictors of help seeking from a general practitioner. British Journal of Health Psychology 15, 213–228.Google Scholar
Tomlinson, MW (2012). War, peace and suicide: the case of Northern Ireland. International Sociology 27, 464–482.Google Scholar
Wolter, KM (2007). Introduction to Variance Estimation, 2nd edn. Springer: New York.Google Scholar
Women's Health Council (2005). Women's Mental Health: Promoting a Gendered Approach to Policy and Service Provision. Women's Health Council: Dublin. Retrieved 29 May 2014 from http://www.drugsandalcohol.ie/11851/1/WHC_Womens_mental_health.pdf.Google Scholar
World Health Organization, Collaborating Centre for Drug Statistics Methodology (2012). Guidelines for ATC Classification System and DDD Assignment. WHO: Oslo.Google Scholar